Amicus Therapeutics, Inc. (NASDAQ:FOLD) has scheduled a conference call for 10th August 2020 at 8:30 AM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.amicusrx.com
Earnings Expectation
Amicus Therapeutics, Inc. is set to announce second quarter earning results on Monday 10th August 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, FOLD to report 2Q20 loss of $ 0.26 per share from revenue of $ 62.38 million. For the full year, analysts anticipate top line of $ 254.82 million, while looking forward to loss of $ 1.07 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 250.00 million ~ $ 260.00 million
Click Here For More Historical Outlooks Of Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting a Phase 1/2 clinical study of ATB200-02 for indications, including pompe disease.
